Obinutuzumab in Refractory Phospholipase A2 receptor-Associated Membranous Nephropathy With Severe CKD

Kidney Int Rep. 2023 Jan 31;8(4):942-943. doi: 10.1016/j.ekir.2023.01.035. eCollection 2023 Apr.
No abstract available